Bloomberg is reporting that unnamed sources have said that Lowe’s Companies, Inc (NYSE: LOW) is working with Goldman Sachs to search for acquisitions in Brazil. Options apparently include buying part of BR Home Centers, a home-improvement holding company valued at about 500 million reais ($220.1 million) that is said to be working with Rothschild to study strategic options plus Curitiba-based Balaroti Materiais de Construcao SA, which is said to be working with Morgan Stanley
Home improvement retailers see a potentially big market as tens of millions of Brazilians have entered the middle class in the past decade while the formal home-improvement industry still competes with corner hardware stores. In addition, the government has encouraged home ownership with its low-income housing initiative dubbed Minha Casa, Minha Vida or My Home, My Life program.
It should also be mentioned that both Lowe’s Companies and rival Home Depot, Inc (NYSE: HD) have a presence in Mexico but both have yet to really penetrate the rest of Latin America.
To read the whole article, Lowe’s Said to Hire Goldman to Find Brazil Acquisitions, go to the website of Bloomberg.
Similar Posts:
- Stocks with 10% or More Sales Exposure to Brazil (Goldman Sachs)
- Bloomberg Quicktake: Brazil’s Highs and Lows
- On the Ground in Brazil (East Capital)
- Latin American Stocks to Consider (Aberdeen)
- Burying the Legal Ghosts of Brazil’s Hyperinflation (Project Syndicate)
- Conservatism Grows in Brazil, Despite Leftist President’s Win (Wall Street Journal)
- Mark Mobius’ Contrarian Case for Investing in Brazil (Mobius Blog)
- Invesco Manager: Brazil a “Sinkhole of Corruption Still Searching for a Bottom” (Forbes)
- Brazil: What’s Gone Wrong Plus Four Scenarios (Miami Herald)
- Which Emerging Markets Have the Most Leveraged Stocks? (Bloomberg)
- Brazil’s Grievous Manufacturing Collapse (The Emerging Markets Investor)
- A Turning Point in Brazil (William Blair)
- 2016 Was Awful for Brazil and 2017 Doesn’t Look Much Better (Bloomberg)
- Brazil Takes Big Reform Step (Franklin Templeton)
- Surviving the Pharma Drug Price Wars in Emerging Markets (PharmExec.com)
